Shinpoong Pharmaceutical Co.,Ltd (KRX:019175)
South Korea flag South Korea · Delayed Price · Currency is KRW
20,000
0.00 (0.00%)
Feb 5, 2026, 3:30 PM KST

KRX:019175 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
39,71941,98643,80041,69127,63755,803
Short-Term Investments
19,92214,47516,24514,22664,599122,872
Trading Asset Securities
--535.69-465.9711,965
Cash & Short-Term Investments
59,64156,46160,58155,91792,702190,639
Cash Growth
-3.89%-6.80%8.34%-39.68%-51.37%188.14%
Accounts Receivable
71,54070,16373,66182,28981,86588,671
Other Receivables
749.622,1558,0838,0817,8607,908
Receivables
72,49572,52381,94590,57689,92596,779
Inventory
59,34055,38253,92346,89547,70749,088
Prepaid Expenses
1,3052,757766.581,008900.48895.93
Other Current Assets
1,8012,1991,7192,1471,7641,174
Total Current Assets
194,582189,321198,935196,542232,997338,577
Property, Plant & Equipment
110,812115,398118,638113,760116,884124,177
Long-Term Investments
25,32924,89621,10729,33628,57114,876
Other Intangible Assets
5,0645,0065,7696,9318,9718,062
Long-Term Deferred Tax Assets
2,8012,826475.256,6289,0865,394
Other Long-Term Assets
2,9984,6335,1598,3391,8411,829
Total Assets
341,594342,093350,084361,536398,350492,915
Accounts Payable
8,7689,9988,94111,42812,0608,789
Accrued Expenses
6,7309,02113,8567,3007,0574,953
Short-Term Debt
42,32147,30545,000-248.11150.17
Current Portion of Long-Term Debt
2,8001,400----
Current Portion of Leases
1,033951.49932.481,487719.941,059
Current Income Taxes Payable
1,256112.5118.11-133.0259,467
Other Current Liabilities
8,1237,0567,5376,9528,3328,919
Total Current Liabilities
71,03275,84476,38527,16728,55083,337
Long-Term Debt
2,7854,600----
Long-Term Leases
217.11340.84218.96441.51212.67575.85
Pension & Post-Retirement Benefits
----7,06526,566
Other Long-Term Liabilities
3,3593,2182,6983,1692,1972,341
Total Liabilities
77,39384,00379,30130,77838,025112,820
Common Stock
27,59227,59227,59227,59227,59227,592
Additional Paid-In Capital
213,592213,592213,592213,592213,592213,592
Retained Earnings
47,30738,94355,331115,830144,925162,361
Treasury Stock
-8,734-8,734-8,734-8,734-8,734-8,734
Comprehensive Income & Other
-16,338-14,573-18,196-18,673-18,118-15,675
Total Common Equity
263,420256,821269,586329,607359,257379,137
Minority Interest
781.021,2691,1961,1511,067958.76
Shareholders' Equity
264,201258,090270,782330,758360,324380,095
Total Liabilities & Equity
341,594342,093350,084361,536398,350492,915
Total Debt
49,15754,59746,1511,9281,1811,785
Net Cash (Debt)
10,4841,86414,43053,98891,521188,854
Net Cash Growth
-45.55%-87.08%-73.27%-41.01%-51.54%-
Net Cash Per Share
209.2636.36281.491053.181785.353752.42
Filing Date Shares Outstanding
49.2751.2649.2749.2749.2749.27
Total Common Shares Outstanding
49.2751.2651.2651.2651.2651.26
Working Capital
123,549113,477122,550169,375204,447255,240
Book Value Per Share
5346.355009.935258.956429.827008.227396.02
Tangible Book Value
258,356251,814263,817322,676350,286371,075
Tangible Book Value Per Share
5243.584912.275146.416294.626833.227238.75
Land
15,97615,97615,97615,97615,97615,976
Buildings
122,788121,660120,117121,946123,266120,809
Machinery
113,686112,867103,969104,000104,22498,806
Construction In Progress
1,0221,1245,4264,231329.34,974
Source: S&P Global Market Intelligence. Standard template. Financial Sources.